Download molecular and translational oncology and

PhD PROGRAMME IN MOLECULAR AND TRANSLATIONAL ONCOLOGY
AND INNOVATIVE MEDICAL-SURGICAL TECHNOLOGIES
Required degree
The programme offers a 3-year PhD course with 12 fellowships per year, and is open to applicants holding a
5-year degree (BSc + MSc or equivalent degree) in biological or pharmaceutical sciences, chemistry,
engineering/informatics, as well as to MDs, with a strong commitment to translational cancer research.
Learning outcomes
Aim of this programme is to provide the trainees with a strong and interdisciplinary expertise in diverse
aspects of cancer biology and basic and translational cancer research. The programme Faculty comprises
qualified Italian and international experts in various basic and clinical cancer-related areas, bio-medical
engineering, nanotechnologies and systems biology.
The programme is articulated in four curricula: Molecular oncology; Biomedical engineering, systems biology
and applied nanotechnologies; Translational medical oncology; Innovative technologies and therapies in
urology and gynecology. Main areas of scientific interests include:










Aberrant signalling in cancer – biochemical and molecular aspects, targeted therapy;
Application of high-throughput approaches for the definition of the genonic, epigenomic,
proteomic and metabolic landscape of haematopoietic and solid malignancies;
Generation of in vitro, ex-vivo and in vivo models for the study of tumourigenesis and for
the discovery and validation of new therapeutic agents;
Stem cell and cancer stem cell biology;
microRNA in cancer development and progression;
Systems biology in cancer research;
Advanced methods of bio- and molecular imaging;
Innovative diagnostics and tailored therapeutics in clinical oncology;
Design of innovative nanotechnology-based bio-medical devices;
Innovative approaches in uro-genital oncological surgery and preservation of fertility in
cancer patients.
Job placement opportunities
Academia, biotechnology or pharmaceutical companies, national health system, national and international
research institutions.
Additional information
This programme, together with the other bio-medical PhD programmes of the University Magna Græcia, is
part of the PhD School “Life Science and Technologies” that co-ordinates their educational activities and
initiatives. The annual reports that illustrates the activities of the academic year 2013/2014 is available here:
http://www.cclab.unicz.it/phd-reports/ar_2013_2014.pdf